Next-generation peptide-based medicines for malaria

The University of Queensland in Australia was awarded a $2,383,881 Project Grant from the Department of the Army Medical Command on September 15, 2022 to complete work by September 14, 2026. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform health care for service members and the public through innovative and impactful research, as well as investigate medical solutions for the battlefield.

Under this award, The University of Queensland will conduct research to develop next-generation peptide-based medicines for malaria. The grant will support the awardee's efforts to advance peptide-based therapeutic approaches for malaria, which has significant impacts on both military personnel and civilians. The research has the potential to deliver new medical solutions in the fight against this infectious disease.